M

Middle East Pharmaceutical Industries Company SJSC
SAU:4016

Watchlist Manager
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Watchlist
Price: 121.2 SAR 1.68% Market Closed
Market Cap: 2.4B SAR
Have any thoughts about
Middle East Pharmaceutical Industries Company SJSC?
Write Note

Relative Value

The Relative Value of one Middle East Pharmaceutical Industries Company SJSC stock under the Base Case scenario is 122.56 SAR. Compared to the current market price of 121.2 SAR, Middle East Pharmaceutical Industries Company SJSC is Undervalued by 1%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
122.56 SAR
Undervaluation 1%
Relative Value
Price
M
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
63
vs Industry
26
Median 3Y
4.8
Median 5Y
4.8
Industry
2.5
Forward
6.2
vs History
63
vs Industry
17
Median 3Y
25.3
Median 5Y
25.3
Industry
21.8
Forward
27.6
vs History
9
vs Industry
21
Median 3Y
24.2
Median 5Y
24.2
Industry
16.1
vs History
36
vs Industry
10
Median 3Y
73.3
Median 5Y
73.3
Industry
23.8
vs History
45
vs Industry
8
Median 3Y
7.4
Median 5Y
7.4
Industry
2.1
vs History
63
vs Industry
24
Median 3Y
4.8
Median 5Y
4.8
Industry
2.7
Forward
6.3
vs History
63
vs Industry
24
Median 3Y
7.7
Median 5Y
7.7
Industry
5.2
vs History
63
vs Industry
18
Median 3Y
19.2
Median 5Y
19.2
Industry
13.5
Forward
22.5
vs History
63
vs Industry
19
Median 3Y
21.3
Median 5Y
21.3
Industry
16.8
Forward
25.1
vs History
9
vs Industry
22
Median 3Y
24.2
Median 5Y
24.2
Industry
15.2
vs History
0
vs Industry
15
Median 3Y
34.7
Median 5Y
34.7
Industry
19.3
vs History
63
vs Industry
14
Median 3Y
6.2
Median 5Y
6.2
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Middle East Pharmaceutical Industries Company SJSC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SA
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
2.4B SAR 4.1 24 17.8 20.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.3B USD 18.5 90.4 48.5 54.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
349.7B USD 4 23.8 11.5 15
US
Merck & Co Inc
NYSE:MRK
251.6B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
200.1B CHF 3.4 17.4 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
162.1B GBP 4.1 31.5 169.4 253.9
CH
Novartis AG
SIX:NOVN
171.5B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
151.4B USD 2.5 35.6 10.6 16
P/E Multiple
Earnings Growth P/E to Growth
SA
M
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Average P/E: 31.5
24
89%
0.3
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
90.4
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.8
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.6
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SA
M
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Average EV/EBITDA: 415.4
17.8
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.5
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.5
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.6
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SA
M
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Average EV/EBIT: 1 812.2
20.3
79%
0.3
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.2
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
15
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.9
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
16
68%
0.2

See Also

Discover More
Back to Top